Search
3 results for “United Therapeutics Corporation”
| Case | Title | Lower Court | Docketed | Status | Tags | Question Presented |
|---|---|---|---|---|---|---|
| 23-1298 | United Therapeutics Corporation v. Liquidia Technologies, Inc. | Federal Circuit | 2024-06-12 | Denied | administrative-law chevron chevron-deference civil-procedure inter-partes-review judicial-review patent patent-review standing statutory-interpretation | Whether the IPR statute and SAS require the Federal Circuit to review de novo, or only for an abuse of discretion, the PTO's reliance on new grounds a… |
| 23-804 | Liquidia Technologies, Inc. v. United Therapeutics Corporation | Federal Circuit | 2024-01-25 | Denied | administrative-law federal-circuit induced-infringement inter-partes-review patent-infringement patent-validity preclusion preclusion-doctrine ptab statutory-framework | Whether a party may be liable for induced patent infringement when the PTAB has already issued a final written decision determining that the same pate… |
| 23A565 | Liquidia Technologies, Inc. v. United Therapeutics Corporation | Federal Circuit | 2023-12-19 | Presumed Complete | administrative-preclusion biotechnology-patents inter-partes-review issue-estoppel patent-infringement patent-validity | Whether a Patent Trial and Appeal Board (PTAB) decision finding patent claims unpatentable can serve as a defense to induced patent infringement befor… |